NASDAQ:UTMD - Utah Medical Products Stock Price, News & Analysis

+0.02 (+0.02 %)
(As of 08/23/2019 08:26 AM ET)
Today's Range
Now: $93.05
50-Day Range
MA: $90.23
52-Week Range
Now: $93.05
Volume5,756 shs
Average Volume11,692 shs
Market Capitalization$346.15 million
P/E Ratio25.50
Dividend Yield1.18%
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
Current SymbolNASDAQ:UTMD



Sales & Book Value

Annual Sales$42 million
Cash Flow$4.9155 per share
Book Value$25.25 per share


Net Income$18.56 million


Market Cap$346.15 million
Next Earnings Date10/22/2019 (Estimated)
OptionableNot Optionable

Receive UTMD News and Ratings via Email

Sign-up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter.

Utah Medical Products (NASDAQ:UTMD) Frequently Asked Questions

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products declared a quarterly dividend on Thursday, August 8th. Stockholders of record on Friday, September 13th will be given a dividend of $0.275 per share on Thursday, October 3rd. This represents a $1.10 annualized dividend and a dividend yield of 1.18%. The ex-dividend date of this dividend is Thursday, September 12th. View Utah Medical Products' Dividend History.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) released its quarterly earnings data on Thursday, April, 25th. The medical instruments supplier reported $0.84 EPS for the quarter. The medical instruments supplier had revenue of $10.73 million for the quarter. Utah Medical Products had a return on equity of 15.13% and a net margin of 39.37%. View Utah Medical Products' Earnings History.

When is Utah Medical Products' next earnings date?

Utah Medical Products is scheduled to release their next quarterly earnings announcement on Tuesday, October 22nd 2019. View Earnings Estimates for Utah Medical Products.

Has Utah Medical Products been receiving favorable news coverage?

Media coverage about UTMD stock has trended positive recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Utah Medical Products earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the company's share price in the immediate future. View News Stories for Utah Medical Products.

Are investors shorting Utah Medical Products?

Utah Medical Products saw a decline in short interest during the month of July. As of July 31st, there was short interest totalling 169,700 shares, a decline of 15.9% from the June 30th total of 201,800 shares. Based on an average trading volume of 21,300 shares, the days-to-cover ratio is currently 8.0 days. Approximately 4.9% of the company's shares are sold short. View Utah Medical Products' Current Options Chain.

Who are some of Utah Medical Products' key competitors?

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include ZIX (ZIXI), UnitedHealth Group (UNH), Maxwell Technologies (MXWL), Prothena (PRTA), Trupanion (TRUP), Express Scripts (ESRX), Goodyear Tire & Rubber (GT), Malibu Boats (MBUU), Meet Group (MEET) and NVIDIA (NVDA).

Who are Utah Medical Products' key executives?

Utah Medical Products' management team includes the folowing people:
  • Mr. Kevin L. Cornwell, Chairman, CEO, Pres & Sec. (Age 72)
  • Mr. Brian L. Koopman, Principal Financial Officer & Controller

Who are Utah Medical Products' major shareholders?

Utah Medical Products' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (8.75%), Renaissance Technologies LLC (6.68%), BlackRock Inc. (5.78%), Vanguard Group Inc. (5.04%), Ancora Advisors LLC (2.45%) and Russell Investments Group Ltd. (2.45%). Company insiders that own Utah Medical Products stock include Barbara A Payne, Ernst G Hoyer and Kevin L Cornwell. View Institutional Ownership Trends for Utah Medical Products.

Which institutional investors are selling Utah Medical Products stock?

UTMD stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, THB Asset Management, Wedge Capital Management L L P NC, Marshall Wace LLP, AQR Capital Management LLC, Prudential Financial Inc., Chicago Equity Partners LLC and Cambridge Investment Research Advisors Inc.. View Insider Buying and Selling for Utah Medical Products.

Which institutional investors are buying Utah Medical Products stock?

UTMD stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., BlackRock Inc., Rice Hall James & Associates LLC, Ancora Advisors LLC, Renaissance Technologies LLC, Price T Rowe Associates Inc. MD, Everett Harris & Co. CA and Municipal Employees Retirement System of Michigan. View Insider Buying and Selling for Utah Medical Products.

How do I buy shares of Utah Medical Products?

Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $93.05.

How big of a company is Utah Medical Products?

Utah Medical Products has a market capitalization of $346.15 million and generates $42 million in revenue each year. Utah Medical Products employs 173 workers across the globe.View Additional Information About Utah Medical Products.

What is Utah Medical Products' official website?

The official website for Utah Medical Products is

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at 801-566-1200.

MarketBeat Community Rating for Utah Medical Products (NASDAQ UTMD)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  157 (Vote Underperform)
Total Votes:  274
MarketBeat's community ratings are surveys of what our community members think about Utah Medical Products and other stocks. Vote "Outperform" if you believe UTMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UTMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/23/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel